Community clinic in Oxfordshire boosts access to schizophrenia treatment
Study shows community service reduces delays for clozapine therapy
A new study has highlighted the positive impact of Oxford Health NHS Foundation Trust's (OHFT) TUNE-UP clinic, enabling more patients to safely start clozapine, a treatment for schizophrenia, in the community.
The study, published in BJPsych OPEN and supported by the National Institute for Health and Care Research Oxford Health Biomedical Research Centre, examined the OHFT's innovative Treating Unmet Needs in Psychiatry TUNE-UP clinic.
Clozapine is the only evidence-based treatment for individuals with treatment-resistant schizophrenia, but many patients face delays in accessing it because the process typically requires an inpatient stay.
The TUNE-UP service was introduced to tackle this challenge by establishing a community-based pathway, delivered by OHFT specialist clinicians in collaboration with the University of Oxford's Department of Psychiatry.
During the first year, the clinic's operations led to a more than six-fold increase in community clozapine initiations compared to times without the service.
Through intensive assessments, collaborative care planning, and community-based titration, the TUNE-UP clinic allows eligible patients to begin clozapine without needing hospital admission.
Author Robert McCutcheon, Associate Professor of Psychiatry and OHFT Honorary Consultant Psychiatrist said: “This paper highlights what’s possible when academic insight and frontline clinical expertise are brought together.
“By developing a safe and effective community pathway for clozapine initiation — within a wider service focused on complex treatment optimisation — we’ve been able to reach patients who might otherwise face long delays or avoid treatment altogether.
"The results show that targeted, collaborative services can make a real difference for people living with severe mental illness, and we hope this model will inform similar approaches across the NHS.”
The authors of the study suggest that community-focused services like TUNE-UP could be scaled nationally, improving access to clozapine and addressing broader clinical needs, thereby enhancing patient outcomes and experiences.